Risk-adapted preemptive therapy for cytomegalovirus disease after allogeneic stem cell transplantation: a single-center experience in Korea

Int J Hematol. 2006 Apr;83(3):277-8. doi: 10.1007/BF02985486.
No abstract available

Publication types

  • Comment
  • Comparative Study
  • Letter

MeSH terms

  • Antilymphocyte Serum / administration & dosage
  • Cytomegalovirus Infections / prevention & control*
  • Donor Selection
  • Female
  • Humans
  • Incidence
  • Korea
  • Living Donors*
  • Male
  • Monitoring, Physiologic
  • Prospective Studies
  • Risk Factors
  • Stem Cell Transplantation* / adverse effects
  • Transplantation, Homologous

Substances

  • Antilymphocyte Serum